Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 1468.71 Million | USD 3086.05 Million | 8.6% | 2023 |
The global Embolic Protection Devices market size was worth around USD 1468.71 million in 2023 and is predicted to grow to around USD 3086.05 million by 2032 with a compound annual growth rate (CAGR) of roughly 8.6% between 2024 and 2032.
The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Million). The report covers a forecast and an analysis of the Embolic Protection Devices market on a global and regional level.
Embolic protection devices are catheter-shaped devices used to remove debris and extra material during the stenting procedure. These devices contain imaging devices that are used to locate debris. They are generally used when the debris is in the saphenous vein apart from being used in the percutaneous cardiac procedure.
According to the NCBI, in the last 10 years, about 400,000 people worldwide have undergone TAVR procedure, and this number is expected to grow at a rate of 40% annually. This rise in the number of patients suffering from TAVR is likely to contributing toward the global embolic protection devices market growth in the future. According to the World Health Organization, about 18 million people across the world suffer from cardiovascular disease annually, which accounts for about 31% of the total global deaths. The rise in the number of people suffering from cardiovascular diseases is anticipated to further fuel the growth of the embolic protection devices market. The growing awareness about minimally invasive procedures, product launches by companies in developing regions, and growing support by the government for treatment of chronic diseases are also anticipated to fuel the market for embolic protection devices in the future.
The study provides a decisive view of the embolic protection devices market by segmenting it on the basis of type, material, application, indication, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.
By type, the market for embolic protection devices is segmented into proximal occlusion devices, distal occlusion devices, and distal filter devices. Distal filter devices are projected to dominate the market over the forecast time period.
Based on material, the embolic protection devices market is segmented into nitinol and polyurethane. The Nitinol segment has highly specific properties that are required in embolic protection devices, which, in turn, is likely to fuel this segment in the future.
By application, the market is segmented into the peripheral disease, neurovascular disease, and cardiovascular diseases. Neurovascular diseases are anticipated to show the highest growth rate in the upcoming years owing to the growing disease awareness. The indication segment of the market is divided into transcatheter aortic valve replacement, saphenous vein graft disease, percutaneous coronary intervention, carotid artery disease, and others. In 2023, the percutaneous coronary intervention segment dominated the market due to the increasing demand for minimally invasive procedures to treat these disorders.
Based on end-user, the market is segmented ambulatory care centers, hospitals, and others. Hospitals are anticipated to dominate the global embolic protection devices market in the future.
Report Attributes | Report Details |
---|---|
Report Name | Embolic Protection Devices Market |
Market Size in 2023 | USD 1468.71 Million |
Market Forecast in 2032 | USD 3086.05 Million |
Growth Rate | CAGR of 8.6% |
Number of Pages | 110 |
Key Companies Covered | Abbott, W.L. Gore & Associates, Boston Scientific, Allium Medical, Cordis, Medtronic, Contego Medical, Silk Road Medical, AngioSlide, and Claret Medical, among others |
Segments Covered | By type, By material, By application, By indication, By end-user and By region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further segmentation into major countries including the U.S., UK, Germany, France, China, Japan, India, Brazil, etc.
By region, North America is anticipated to dominate the global embolic protection devices market in the upcoming years owing to the increase in the occurrences of cardiovascular disease and rising demand for minimally invasive procedures. The Asia Pacific embolic protection devices market is projected to show the highest growth rate over the forecast time period owing to the prevalence of cardiovascular diseases due to changes in lifestyle, product launches by major companies, raising awareness about the use of embolic protection devices among the surgeons, and increasing investments made by the government for the development of healthcare infrastructure.
Some key players of the global embolic protection devices market are:
Global Embolic Protection Devices Market: Type Analysis
Global Embolic Protection Devices Market: Material Analysis
Global Embolic Protection Devices Market: Application Analysis
Global Embolic Protection Devices Market: Indication Analysis
Global Embolic Protection Devices Market: End-User Analysis
Global Embolic Protection Devices Market: Regional Analysis
FrequentlyAsked Questions
Embolic protection devices are medical devices designed to prevent or reduce the risk of emboli—clots or other debris that can dislodge and travel to distant sites in the body, potentially causing serious complications such as stroke or organ damage.
According to study, the Embolic Protection Devices market size was worth around USD 1468.71 million in 2023 and is predicted to grow to around USD 3086.05 million by 2032.
The CAGR value of Embolic Protection Devices market is expected to be around 8.6% during 2024-2032.
North America has been leading the Embolic Protection Devices market and is anticipated to continue on the dominant position in the years to come.
The Embolic Protection Devices market is led by players like Abbott, W.L. Gore & Associates, Boston Scientific, Allium Medical, Cordis, Medtronic, Contego Medical, Silk Road Medical, AngioSlide, and Claret Medical, among others.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed